Sponsor Pipeline

Qilu Pharmaceutical Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
42
Active Trials
13
Recruiting
14
Phase 3
10
Disease Areas
3
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-06-06 NCT07511647
A Phase 3 Clinical Study of QL2106 Injection
Recruitment opened
2026-05-23 NCT07489612
QLS1410 in Participants With Uncontrolled Hypertension
overall status: "Not Yet Recruiting" → "Enrolling By Invitation"
2026-05-20 NCT07467629
QLS5212 for Participants With Advanced Solid Tumors
Recruitment opened
New Trial Filings, Last 30 Days
First PostedTrialPhaseStatus
2026-06-09 NCT07636707 QLF4113 in Participants With Metastatic Prostate Cancer Phase 1 Not Yet Recruiting
2026-06-08 NCT07632690 QLC5508 in Participants With Metastatic Prostate Cancer Phase 3 Not Yet Recruiting
2026-06-02 NCT07620041 QLC5508 in Advanced Solid Tumors:: C-QTc, Pharmacokinetics (PK) Comparisons and Drug-drug… Phase 1 Not Yet Recruiting
2026-06-02 NCT07620366 To Evaluate the Efficacy and Safety of QL2401 in Patients With Metabolic… Phase 2 Not Yet Recruiting
Active Trials by Phase
Phase 3
13
Phase 2/3
1
Phase 2
9
Phase 1/2
4
Phase 1
15
Active Trials — top 25 of 42
NCT IDTitleConditionStatus
Phase 3
NCT06671548 Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated… Heavy Menstrual Bleeding Recruiting
NCT07327619 A Study to Evaluate the Efficacy and Safety of Meropenem and Pralurbactam in HABP/VABP Hospital-acquired Bacterial Pneumonia and Ventilator-associated Bacterial Pneumonia Recruiting
NCT07463573 QLC5508 vs. Chemotherapy in Pretreated Advanced or Metastatic Esophageal Squamous Cell… Esophageal Squamous Cell Carcinoma (ESCC) Recruiting
NCT07138209 A Study Comparing QLS32015 Monotherapy Versus Pomalidomide, Dexamethasone (Pd) or… Relapsed or Refractory Multiple Myeloma Recruiting
NCT07511647 A Phase 3 Clinical Study of QL2106 Injection Plaque Psoriasis Recruiting
NCT07345000 A Study of Romiplostim N01 Plus IST vs. Placebo Plus IST for Treatment-Naive Severe… Treatment-naïve Severe Aplastic Anemia Not Yet Recruiting
NCT07444086 QLC7401 Monotherapy in Non-familial Hypercholesterolemia or Mixed Dyslipidemia Primary Hypercholesterolemia or Mixed Hyperlipidemia Not Yet Recruiting
NCT07441317 QLC7401 in the Treatment of Primary Hypercholesterolemia or Mixed Hyperlipidemia With… Primary Hypercholesterolemia or Mixed Hyperlipidemia Not Yet Recruiting
NCT07450378 QLC7401 in Participants With Heterozygous Familial Hypercholesterolemia (HeFH) Heterozygous Familial Hypercholesterolemia (HeFH) Not Yet Recruiting
NCT07455006 Safety and Efficacy Study of QL0911 to Treat Immune Thrombocytopenia (ITP) in Pediatric… Thrombocytopenia, Immune Not Yet Recruiting
NCT07489586 A Clinical Study of QL1207H Injection Versus Aflibercept for Neovascular Age-related… Neovascular Age-Related Macular Degeneration (nAMD) Not Yet Recruiting
NCT07487103 Efficacy and Safety of QLG1091 vs Rybelsus as add-on to Metformin in Subjects With Type 2… Type 2 Diabetes Not Yet Recruiting
NCT07632690 QLC5508 in Participants With Metastatic Prostate Cancer Prostate Cancer Not Yet Recruiting
Phase 2/3
NCT06456528 QL0911 for the Treatment of Cancer Treatment-Induced Thrombocytopenia Cancer Treatment-Induced Thrombocytopenia Recruiting
Phase 2
NCT07018050 Phase II Study of QLS32015 Combination Therapy in the Treatment of Multiple Myeloma Relapsed or Refractory Multiple Myeloma Recruiting
NCT07344051 A Phase II Study of QLS12010 Capsules in Adults With Moderate to Severe Atopic Dermatitis Moderate-to-severe Atopic Dermatitis Not Yet Recruiting
NCT07377773 QLS12010 in Participants With Moderate-to-severe Rheumatoid Arthritis Rheumatoid Arthritis (RA) Not Yet Recruiting
NCT07417917 QLS12010 Capsules in Adults With Moderate to Severe Hidradenitis Suppurativa Adults With Moderate-to-severe Hidradenitis Suppurativa Not Yet Recruiting
NCT07550465 Study of QLS1410 in the Treatment of Primary Aldosteronism. Primary Aldosteronism Not Yet Recruiting
NCT07560449 QLS4131 Combination Therapy in Malignant Plasma Cell Neoplasms Malignant Plasma Cell Neoplasms Not Yet Recruiting
NCT07585565 A Study to Evaluate the Efficacy and Safety of Monosialotetrahexosylganglioside Sodium… Parkinson's Disease Not Yet Recruiting
NCT07489612 QLS1410 in Participants With Uncontrolled Hypertension Hypertension (HTN) Enrolling by Invitation
NCT07620366 To Evaluate the Efficacy and Safety of QL2401 in Patients With Metabolic… Metabolic Dysfunction-associated Steatohepatitis (MASH) Not Yet Recruiting
Phase 1/2
NCT06911827 A Study of QLP2117 in Combination With QL2107 in Advanced Solid Tumor Patients Advanced Solid Tumor Recruiting
NCT07235176 Phase Ib/II Clinical Study of QLS1304 Combined With Endocrine Therapy in the Treatment of… Advanced ER+/HER2- Breast Cancer Recruiting
View all 42 active Qilu Pharmaceutical Co., Ltd. trials with filters →
Disease Areas
Get alerts when Qilu Pharmaceutical Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free